ViroCyt

ViroCyt, LLC is the leader in the field of rapid virus quantification. Our goal is to provide the tools that deliver meaningful improvements to mission critical processes, such as vaccine manufacturing, protein expression, antiviral development and other settings where viruses play a significant role.

Recent News

up
down
  • ViroCyt Strengthens Management Team

    BOULDER, CO – (Marketwired – June 11, 2014) - ViroCyt, LLC, the leader in rapid virus quantification, announced today that Michael Olszowy, PhD, has joined the team as Chief Technology Officer. Dr. Olszowy is a formally trained cellular and molecular immunologist with 16 years of experience developing and commercializing life science technologies. Most recently, he held  Continue Reading »

    Read More arrow
  • New Rapid Virus Counter® System Introduced at World Vaccine Congress

    BOULDER, CO–(Marketwired – March 25, 2014) - ViroCyt, LLC, the leader in rapid virus quantification, announced today the introduction of the next generation Virus Counter at the World Vaccine Congress being held in Washington, DC.  The Virus Counter technology has already been adopted by the leading companies in the fields of viral vaccine development and therapeutic  Continue Reading »

    Read More arrow
  • ViroCyt Launches Rapid Virus Cleanup System: ViroPrep® Plus

    DENVER, CO–(Marketwired – Oct 1, 2013) - ViroCyt, LLC, the leader in rapid virus quantification, disclosed today availability of ViroPrep® Plus, a new product developed specifically for the purification of viruses from both egg- and cell-based systems. Quantification of viruses has been and continues to be a major chokepoint in a variety of different settings. These include: viral vaccine  Continue Reading »

    Read More arrow
  • ViroCyt Increases Global Reach

    DENVER, CO–(Marketwired – Aug 7, 2013) - ViroCyt, LLC, the leader in the field of rapid virus quantification, disclosed today the addition of two new distributors to its growing international network. Biotech Europe will sell and support ViroCyt’s Virus Counter in Central and Eastern Europe (CEE) as well as the Commonwealth of Independent States (CIS). CESCO  Continue Reading »

    Read More arrow
  • ViroCyt Launches Improved Virus Counter Reagent System

    DENVER, CO–(Marketwired – Jun 4, 2013) - ViroCyt, LLC, the leader in the field of rapid virus quantification, today announced the availability of the Virus Counter Reagent Kit 200 for use with the Virus Counter 2100. The new system allows up to 200 samples to be run, instead of the previous amount of 50. This results  Continue Reading »

    Read More arrow

Upcoming Events


Jun
22

American Society for Virology 33rd Annual Meeting Event Details

Oct
27

ISBioTech 2nd Annual Fall Meeting Event Details